Vice President, Venture Science, West Coast USA Head, Corp BD
Tim Luker PhD is currently VP Venture Science at Eli Lilly. He leads Lilly’s venture external innovation process on the West Coast USA within Global Corporate Business Development, primarily targeting transformational early stage research across 5 therapy areas. This role supports Lilly’s multiple external venture fund investments globally (>$2bill) and due diligence and search and evaluation initiatives. He has completed over 30 signed deals across multiple modalities and therapeutic areas for Lilly.
Tim is an experienced drug hunter with >20 years’ experience (>60 patents and publications). Prior to Lilly he worked at Shire, Polleo Pharma (founder, company acquired) and AstraZeneca.
Tim has a PhD in chemistry from the University of Southampton, UK, carried out post-doctoral research at Universiteit Van Amsterdam and is a Prince2 qualified project manager.